TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy
| Autor: | Dennis W. Dickson, Jennifer S. Yokoyama, Alma L. Burlingame, Eliana Marisa Ramos, Carolina Alquezar, Gerard D. Schellenberg, Beth A. Dombroski, Ana Maria Cuervo, Kathleen M. Schoch, Aimee W. Kao, Aurora Scrivo, Elisabeth E. Mlynarski, Ethan G. Geier, Michael DeTure, Bruce L. Miller, Andrea R. Argouarch, Kathy H. Li, Timothy M. Miller |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
congenital
hereditary and neonatal diseases and abnormalities Mutation Multidisciplinary Chemistry SciAdv r-articles medicine.disease medicine.disease_cause Cell biology medicine.anatomical_structure Chaperone-mediated autophagy Acetylation Cellular Neuroscience mental disorders medicine TSC1 Tauopathy Gene Intracellular Research Article Neuroscience |
| Zdroj: | Science Advances |
| ISSN: | 2375-2548 |
| Popis: | Description TSC1/hamartin haploinsufficiency increases risk for tauopathy by promoting tau acetylation and accumulation. Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions are known as tauopathies. We previously linked a loss-of-function mutation in the TSC1 gene to tau accumulation and frontotemporal lobar degeneration. Now, we have identified genetic variants in TSC1 that decrease TSC1/hamartin levels and predispose to tauopathies such as Alzheimer’s disease and progressive supranuclear palsy. Cellular and murine models of TSC1 haploinsufficiency, as well as human brains carrying a TSC1 risk variant, accumulated tau protein that exhibited aberrant acetylation. This acetylation hindered tau degradation via chaperone-mediated autophagy, thereby leading to its accumulation. Aberrant tau acetylation in TSC1 haploinsufficiency resulted from the dysregulation of both p300 acetyltransferase and SIRT1 deacetylase. Pharmacological modulation of either enzyme restored tau levels. This study substantiates TSC1 as a novel tauopathy risk gene and includes TSC1 haploinsufficiency as a genetic model for tauopathies. In addition, these findings promote tau acetylation as a rational target for tauopathy therapeutics and diagnostic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|